117 related articles for article (PubMed ID: 37345584)
1. Is the prognosis of T1-2N1 colon cancer the same as that of T1-2N0 colon cancer after curative surgery?
Pian G; Oh SY
Scand J Gastroenterol; 2023; 58(11):1286-1294. PubMed ID: 37345584
[No Abstract] [Full Text] [Related]
2. Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1-2N1) colon cancer.
Kim MJ; Jeong SY; Choi SJ; Ryoo SB; Park JW; Park KJ; Oh JH; Kang SB; Park HC; Heo SC; Park JG
Ann Surg Oncol; 2015 Feb; 22(2):505-12. PubMed ID: 25145501
[TBL] [Abstract][Full Text] [Related]
3. Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer.
Shimizu H; Kuriu Y; Arita T; Kiuchi J; Yamamoto Y; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
World J Surg; 2021 May; 45(5):1561-1568. PubMed ID: 33538878
[TBL] [Abstract][Full Text] [Related]
4. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database.
Smith DD; Schwarz RR; Schwarz RE
J Clin Oncol; 2005 Oct; 23(28):7114-24. PubMed ID: 16192595
[TBL] [Abstract][Full Text] [Related]
5. Positive surgical margins contribute to the survival paradox between patients with stage IIB/C (T4N0) and stage IIIA (T1-2N1, T1N2a) colon cancer.
Chu QD; Zhou M; Medeiros K; Peddi P
Surgery; 2016 Nov; 160(5):1333-1343. PubMed ID: 27425043
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis in a Chinese population with T1-2N1 breast cancer: Did patients with 1 or 2, and 3 positive axillary lymph nodes have similar survival outcomes?
Shen H; Yuan J; Yang Y; Liu X; Wang L; Feng X; Zhao L; Niu Y
J Surg Oncol; 2015 Nov; 112(6):569-74. PubMed ID: 26458282
[TBL] [Abstract][Full Text] [Related]
7. Lymph node evaluation and survival after curative resection of colon cancer: systematic review.
Chang GJ; Rodriguez-Bigas MA; Skibber JM; Moyer VA
J Natl Cancer Inst; 2007 Mar; 99(6):433-41. PubMed ID: 17374833
[TBL] [Abstract][Full Text] [Related]
8. Postmastectomy radiotherapy in patients with T
Luo M; Jin Y; Xu C; Chen H; Zhang K; Chen Q; Jin C; Lu J; Wang J; Huang J; Deng H; Jin W; Zheng S; Chen Y; Zhou J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9979-9990. PubMed ID: 37256383
[TBL] [Abstract][Full Text] [Related]
9. Impact of Anatomic Extent of Nodal Metastasis on Adjuvant Chemotherapy Outcomes in Stage III Colon Cancer.
Woo IT; Park JS; Kang BW; Park SY; Kim HJ; Choi GS; Gwang Kim J
Dis Colon Rectum; 2020 Oct; 63(10):1455-1465. PubMed ID: 32969889
[TBL] [Abstract][Full Text] [Related]
10. Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1-2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy.
Chu QD; Zhou M; Medeiros KL; Peddi P; Kavanaugh M; Wu XC
BMC Cancer; 2016 Jul; 16():460. PubMed ID: 27412163
[TBL] [Abstract][Full Text] [Related]
11. Outcome of postmastectomy radiotherapy after primary systemic treatment in patients with clinical T1-2N1 breast cancer.
Cao L; Ou D; Shen KW; Cai G; Cai R; Xu F; Zhao SG; Xu C; Grellier Adedjouma N; Kirova YM; Chen JY
Cancer Radiother; 2018 Feb; 22(1):38-44. PubMed ID: 29306555
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
[TBL] [Abstract][Full Text] [Related]
13. Postmastectomy radiation therapy and survival outcome in older patients with T1-2N1 breast cancer.
Luo C; Zhong X; Luo T; Zheng H
Breast; 2021 Oct; 59():308-313. PubMed ID: 34388696
[TBL] [Abstract][Full Text] [Related]
14. T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center.
Rottoli M; Stocchi L; Dietz DW
Ann Surg Oncol; 2012 Aug; 19(8):2500-5. PubMed ID: 22395999
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer.
Huh JW; Kim CH; Kim HR; Kim YJ
J Surg Oncol; 2012 Feb; 105(2):125-9. PubMed ID: 21837680
[TBL] [Abstract][Full Text] [Related]
16. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
Wang J; Liu Y; Shayan G; Ma Y; Yi J
Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
[TBL] [Abstract][Full Text] [Related]
18. Reconsidering N component of cancer staging for T1-2N0-2M0 small-cell lung cancer: a retrospective study based on multicenter cohort.
Wu LL; Qiu LH; Chen X; Yu WJ; Li CW; Qian JY; Liang SH; Lin P; Long H; Zhang LJ; Li ZX; Li K; Jiang F; Ma GW; Xie D
Respir Res; 2023 Jun; 24(1):168. PubMed ID: 37353782
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.
Biffi R; Botteri E; Bertani E; Zampino MG; Cenciarelli S; Luca F; Pozzi S; Cossu ML; Chiappa A; Rotmensz N; Bazolli B; Magni E; Sonzogni A; Andreoni B
Int J Colorectal Dis; 2013 Feb; 28(2):207-15. PubMed ID: 22903336
[TBL] [Abstract][Full Text] [Related]
20. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
Liao YT; Lin YL; Huang J; Hung JS; Lin BR
Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
